Publications by authors named "Kate S Harris"
Article Synopsis
- The development of differentiation therapy for Acute Myeloid Leukemia (AML) could significantly enhance patient outcomes globally.
- Our lab has identified a new class of agents that successfully reduce tumors in mouse models.
- We optimized a compound (OXS007417) for better effectiveness and safety, and discovered improved versions (OXS008255 and OXS008474) that showed better pharmacokinetics and delayed tumor growth in tests with HL-60 cells.
